Virus Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Virus Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Gene Therapy
CytoGenix and USAMRIID to Collaborate in Developing Biodefense synDNA Vaccines
April 10th, 2007
CytoGenix, Inc. (CYGX.OB) announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID). Scientists from CytoGenix and USAMRIID, led by Dr. Connie Schmaljohn, intend to develop and test synDNA(TM) vaccines for the prevention of disease caused by the Ebola virus and several strains of equine encephalitis viruses. Dr. Malcolm Skolnick, CytoGenix Chief Executive Officer, stated, "We are pleased to have the opportunity to work with Dr. Schmaljohn and the USAMRIID team at Fort Detrick. These disease targets are listed as Category A & B...
Source: Virus Weekly (2007-04-10)
|
